Key result
Genetic analysis of 58 Mexican patients with primary hypertriglyceridemia identified 74 variants across APOA5, GPIHBP1, LMF1, and LPL genes, including 15 potentially pathogenic variants.
Why the study?
In Mexico, hypertriglyceridemia represents a health problem in which the genetic bases have been scarcely explored.
Observational (n=58)
The study identifies novel and rare genetic variants contributing to primary hypertriglyceridemia in Mexican patients, expanding the genetic understanding of this condition.
No takes yet. Share an insight, caveat, or question.
Highlights need for population-specific genetic evaluation in primary hypertriglyceridemia; leaves open functional validation of variants.
Rodríguez-Gutiérrez et al. (2022) conducted an observational in Primary hypertriglyceridemia (n=58). Genetic variants in APOA5, GPIHBP1, LMF1, and LPL genes was evaluated on Genetic variants and clinical-biochemical features. Genetic analysis of 58 Mexican patients with primary hypertriglyceridemia identified 74 variants across APOA5, GPIHBP1, LMF1, and LPL genes, including 15 potentially pathogenic variants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: